论文部分内容阅读
目的对比探讨利凡诺与利凡诺配伍米非司酮用于引产中的效果,为临床引产提供最佳方案。方法对2008年10月至2010年12月来计划生育科要求终止妊娠的78例中期妊娠妇女,随机分为实验组和对照组,分别用利凡诺配伍米非司酮和单独利凡诺治疗,记录两组孕妇从给药到胎儿娩出时间、药物的不良反应、产后出血量、清宫率、住院时间及失败率,对比二者的治疗效果和不良反应。结果实验组和对照组孕妇从给药到胎儿娩出时间、产后出血量、住院时间方面均无显著性差异,但实验组引产成功率、清宫率较对照组高,产程明显较利凡诺组短且无明显的不良反应及并发症。结论利凡诺配伍米非司酮用于引产是一种安全可靠有效方便的引产方法,值得在临床推广。
Objective To compare the effects of rivanol with rivanol in combination with mifepristone for induction of labor and provide the best plan for clinical induction of labor. Methods Seventy-eight interim pregnant women who requested termination of pregnancy from the family planning department from October 2008 to December 2010 were randomly divided into experimental group and control group, with rivanol and mifepristone alone and rivanol alone , Recorded two groups of pregnant women from administration to the time of delivery of the fetus, adverse drug reactions, postpartum hemorrhage, clearance rate, length of stay and failure rate, the two compared the treatment and adverse reactions. Results The experimental group and the control group pregnant women from administration to the fetus delivery time, postpartum hemorrhage, length of stay were no significant differences, but the experimental group, the success rate of induction of labor, clearance rate higher than the control group, labor was significantly shorter than rivanol group And no obvious adverse reactions and complications. Conclusions Rivarivir in combination with mifepristone for induction of labor is a safe, reliable and effective induction of labor, which is worthy of clinical promotion.